Differentiating Malignant from Tubercular Pleural Effusion by Cancer Ratio Plus (Cancer Ratio: Pleural Lymphocyte Count)

Background. We performed prospective validation of the cancer ratio (serum LDH : pleural ADA ratio), previously reported as predictive of malignant effusion retrospectively, and assessed the effect of combining it with “pleural lymphocyte count” in diagnosing malignant pleural effusion (MPE). Method...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Can Respir J
Autors principals: Verma, Akash, Dagaonkar, Rucha S., Marshall, Dominic, Abisheganaden, John, Light, R. W.
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2016
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5192296/
https://ncbi.nlm.nih.gov/pubmed/28070157
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/7348239
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars